SCHEMBL10639901

SCHEMBL10639901

CCCc1cc(Cl)c(Cl)cc1O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HMGCR P04035 2/20 0.53
▸ TSHR P16473 3/20 0.44
▸ HPGD P15428 2/20 0.44
▸ HSD17B10 Q99714 2/20 0.44
▸ ALOX15 P16050 2/20 0.41
▸ ALOX12 P18054 1/20 0.41
▸ ALOX5 P09917 4/20 0.41
▸ PTPN1 P18031 1/20 0.40
▸ PTPN11 Q06124 1/20 0.40
▸ TYR P14679 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ LMNA P02545 1/20 0.39
▸ XBP1 P17861 1/20 0.39
▸ HIF1A Q16665 1/20 0.39
▸ CNR1 P21554 1/20 0.38
▸ CNR2 P34972 1/20 0.38
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ TDP1 Q9NUW8 2/20 0.37
▸ CYP3A4 P08684 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8764455 0.89 HMGCR (0.52) HMGCRTSHRHPGDHSD17B10ALOX15
SCHEMBL16736863 0.89 HMGCR (0.52) HMGCRTSHRHSD17B10ALOX15ALOX12
SCHEMBL16736876 0.85 HMGCR (0.48) HMGCRHSD17B10ALOX15ALOX12ALOX5
SCHEMBL574286 0.85 HMGCR (0.48) HMGCRTSHRHPGDALOX15ALOX5
SCHEMBL10940941 0.84 TSHR (0.48) HMGCRTSHRHPGDHSD17B10ALOX15
SCHEMBL1760537 0.83 HMGCR (0.64) HMGCRTSHRHSD17B10ALOX15ALOX5
SCHEMBL16736725 0.82 TYR (0.50) HMGCRTSHRHPGDALOX15ALOX12
SCHEMBL16736776 0.82 TYR (0.50) HMGCRTSHRHPGDALOX15ALOX12
SCHEMBL13767807 0.81 HPGD (0.48) TSHRHPGDHSD17B10ALOX15ALOX12
SCHEMBL16736718 0.81 HMGCR (0.44) HMGCRALOX15ALOX12PTPN1PTPN11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4764521-A Leukotriene antagonists and a method of use there as ELI LILLY AND COMPANY (US) 1988-08-16 — — US disclosed
EP-0132367-B1 LEUKOTRIENE ANTAGONISTS ELI LILLY AND COMPANY (US) 1988-06-08 — — EP disclosed
EP-0118377-B1 PROCESS FOR THE PRODUCTION OF METACHLORINATED PHENOLS RHONE-POULENC CHIMIE (FR) 1988-03-09 — — EP disclosed
EP-0132367-A2 Leukotriene antagonists ELI LILLY AND COMPANY (US) 1985-01-30 — — EP disclosed
EP-0118377-A2 Process for the production of metachlorinated phenols RHONE-POULENC CHIMIE (FR) 1984-09-12 — — EP disclosed
EP-0055196-B1 PROCESS FOR THE SYNTHESIS OF METACHLOROPHENOLS RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1984-04-18 — — EP disclosed
EP-0055198-B1 PROCESS FOR THE SYNTHESIS OF METACHLOROPHENOLS RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1984-04-04 — — EP disclosed
EP-0055197-B1 PROCESS FOR THE SYNTHESIS OF METACHLOROPHENOLS RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1984-04-04 — — EP disclosed
EP-0055196-A1 Process for the synthesis of metachlorophenols RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1982-06-30 — — EP disclosed
EP-0055197-A1 Process for the synthesis of metachlorophenols RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1982-06-30 — — EP disclosed
EP-0055198-A1 Process for the synthesis of metachlorophenols RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1982-06-30 — — EP disclosed
Send feedback